These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15753204)

  • 1. Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis.
    da Costa CE; Annels NE; Faaij CM; Forsyth RG; Hogendoorn PC; Egeler RM
    J Exp Med; 2005 Mar; 201(5):687-93. PubMed ID: 15753204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts.
    Liu B; Yu SF; Li TJ
    J Oral Pathol Med; 2003 Jul; 32(6):367-75. PubMed ID: 12787044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma with osteoclast-like giant cells: possibility of osteoclastogenesis by hepatocyte-derived cells.
    Ikeda T; Seki S; Maki M; Noguchi N; Kawamura T; Arii S; Igari T; Koike M; Hirokawa K
    Pathol Int; 2003 Jul; 53(7):450-6. PubMed ID: 12828610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multinucleated giant cells with an osteoclast phenotype derived from caprine peripheral blood mononuclear cells.
    Pisoni G; D'Amelio P; Sassi F; Manarolla G; Scaccabarozzi L; Locatelli C; Mazzocchi N; Baruscotti M; DiFrancesco D; Moroni P
    Vet J; 2011 Sep; 189(3):361-3. PubMed ID: 20822938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD14- mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst.
    Taylor RM; Kashima TG; Hemingway FK; Dongre A; Knowles HJ; Athanasou NA
    Lab Invest; 2012 Apr; 92(4):600-5. PubMed ID: 22330339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage colony-stimulating factor and receptor activator NF-kappaB ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro.
    Flanagan AM; Massey HM; Wilson C; Vellodi A; Horton MA; Steward CG
    Bone; 2002 Jan; 30(1):85-90. PubMed ID: 11792569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
    J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANK signalling in bone lesions with osteoclast-like giant cells.
    Won KY; Kalil RK; Kim YW; Park YK
    Pathology; 2011 Jun; 43(4):318-21. PubMed ID: 21532526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular mechanisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jaw.
    Itonaga I; Hussein I; Kudo O; Sabokbar A; Watt-Smith S; Ferguson D; Athanasou NA
    J Oral Pathol Med; 2003 Apr; 32(4):224-31. PubMed ID: 12653862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation.
    Kim MS; Day CJ; Morrison NA
    J Biol Chem; 2005 Apr; 280(16):16163-9. PubMed ID: 15722361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
    Adamopoulos IE; Wordsworth PB; Edwards JR; Ferguson DJ; Athanasou NA
    Hum Pathol; 2006 Sep; 37(9):1176-85. PubMed ID: 16938523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF, FLT3 ligand, PlGF and HGF can substitute for M-CSF to induce human osteoclast formation: implications for giant cell tumour pathobiology.
    Taylor RM; Kashima TG; Knowles HJ; Athanasou NA
    Lab Invest; 2012 Oct; 92(10):1398-406. PubMed ID: 22906984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
    Hayashi S; Yamada T; Tsuneto M; Yamane T; Takahashi M; Shultz LD; Yamazaki H
    J Immunol; 2003 Nov; 171(10):5130-9. PubMed ID: 14607912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.
    Kartsogiannis V; Zhou H; Horwood NJ; Thomas RJ; Hards DK; Quinn JM; Niforas P; Ng KW; Martin TJ; Gillespie MT
    Bone; 1999 Nov; 25(5):525-34. PubMed ID: 10574572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin has a crucial role in osteoclast-like multinucleated giant cell formation.
    Oh Y; Oh I; Morimoto J; Uede T; Morimoto A
    J Cell Biochem; 2014 Mar; 115(3):585-95. PubMed ID: 24129963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoclast-like cells in soft tissue leiomyosarcomas.
    Gibbons CL; Sun SG; Vlychou M; Kliskey K; Lau YS; Sabokbar A; Athanasou NA
    Virchows Arch; 2010 Mar; 456(3):317-23. PubMed ID: 20127110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
    Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
    Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
    Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.